Transaktioner

Alla transaktioner

Vi genomför olika transaktioner som varierar i typ, storlek och struktur. Utforska dem här.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s warrant exercise

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

DecideAct A/S

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Qlife has developed and patented the Egoo Health test platform, which integrates several technologies that potentially can test for a wide range of biomarkers and viruses – protein-based and molecular.

Sound Dimension AB

Sound Dimension secures a bridge loan of 1.2 MSEK

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Stenocare A/S

Gemstone act as financial advisor in Stenocares establishment of a convertible loan facility

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s directed issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Brain+ A/S

Gemstone Capital acted as financial advisor for Brain+ in their IPO

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.

Sound Dimension AB

Gemstone Capital acted as financial advisor for Sound Dimension in their IPO

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Spermosens AB

Gemstone acted as financial advisor for Spermosens in their IPO

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.

Företrädesemission

En företrädesemission ger befintliga ägare i ett bolag företräde att investera ytterligare i bolaget, om så önskas.

DecideAct A/S

Gemstone acted as finacial advisor in DecideAct’s rights issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s rights issue

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

Prostatype Genomics

Gemstone acts as financial advisor in Prostatype Genomics’ Unit Rights Issue

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test Prostatype®. Prostatype® is a genetic test that provides a comprehensive assessment of the aggressiveness of prostate cancer.

Realfiction Holding AB

Gemstone acted as the Danish advisor in Realfiction’s rights issue

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.

Menupay AB

Gemstone acted as financial advisor for menupay in their rights issue

MenuPay was an international technology company, based in Denmark and listed in Sweden on Spotlight Stockmarket, that digitised the relationship between restaurants, businesses and their employees.

Brain+ A/S

Gemstone acted as financial advisor in Brain+’s unit rights issue

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.

Spermosens AB

Gemstone acted as joint financial advisor and joint bookrunner in Spermonsens’ rights issue

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s Unit Rights Issue

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

Sound Dimension AB

Gemstone was financial advisor in Sound Dimension’s unit rights issue

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Riktad emission

Vid en riktad emission frångås befintliga ägares företrädesrätt att teckna aktier, vilket gör att den typiskt sett går snabbare att genomföra än en företrädesemission.

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s directed issue

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Realfiction Holding AB

Gemstone acted as the Danish advisor for Realfiction in their directed issue

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.

Stenocare A/S

Gemstone acted as financial advisor for Stenocare in a Private Placement

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

Börsintroduktion

Vid en riktad emission frångås befintliga ägares företrädesrätt att teckna aktier, vilket gör att den typiskt sett går snabbare att genomföra än en företrädesemission.

Brain+ A/S

Gemstone Capital acted as financial advisor for Brain+ in their IPO

Brain+ is a pioneer in developing medical software to treat the cognitive symptoms of dementia, and the most common cause of dementia, namely Alzheimer’s disease.

Sound Dimension AB

Gemstone Capital acted as financial advisor for Sound Dimension in their IPO

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Spermosens AB

Gemstone acted as financial advisor for Spermosens in their IPO

Spermosen’s goal is to improve male fertility diagnosis and treatment through the introduction of breakthrough products.

DecideAct A/S

Gemstone acted financial advisor for DecideAct in their IPO

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s IPO

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

Realfiction Holding AB

Gemstone was financial advisor for Realfiction in their IPO

Founded in Denmark in 2008, Realfiction is a leading innovator and provider of mixed-reality solutions and services, a market estimated to reach USD 80 billion by 2025.

ExpreS2ion Biotech Holding AB

Gemstone acted as financial advisor in ExpreS2ion Biotech’s IPO

ExpreS2ion Biotechnologies has created a platform technology to enable the cost-effective and safe production of complex proteins, which are the active ingredient in new vaccines and thus also an important basis in diagnostics, research and development of these new vaccines.

Omnicar Holding AB

Gemstone was financial advisor for Omnicar in their IPO

OmniCar has developed a software solution for the car industry. The solution is developed for Citroën in Scandinavia and has been developed by OMI A/S (‘OMI’), a digital marketing agency started by OmniCar co-founder and board member Claus T. Hansen. OmniCar is a spin-off from OMI.

Freetrailer Group A/S

Gemstone acted as Financial advisor to Freetrailer in their IPO

Freetrailer has developed a digital platform that uses the Freelock electronic lock in combination with an combination with an application makes it possible to reserve, collect and return a trailer.

Utnyttjande av teckningsoptioner

Företag kan ge ut teckningsoptioner, som ger investerare och anställda möjlighet att teckna nya aktier till ett potentiellt fördelaktigt pris senare.

Stenocare A/S

Gemstone acted as financial advisor in Stenocare’s warrant exercise

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

Fusioner och förvärv

Transaktioner som rör fusioner och förvärv, vilket omfattar köp och försäljning av företag.

Det finns inga transaktioner inom denna kategori

Lånefinansiering

Kapital kan anskaffas genom lån, där transaktioner som konvertibellån och brygglån är vanliga metoder.

Qlife Holding AB

Gemstone acted as financial advisor in Qlife’s directed issue of convertibles

Qlife has developed and patented the Egoo Health test platform, which integrates several technologies that potentially can test for a wide range of biomarkers and viruses – protein-based and molecular.

Sound Dimension AB

Sound Dimension secures a bridge loan of 1.2 MSEK

Sound Dimension AB is active in the technology sector. The company specialises in the development of technological solutions that combine audio technology and artificial intelligence.

Stenocare A/S

Gemstone act as financial advisor in Stenocares establishment of a convertible loan facility

Stenocare is a Danish pharmaceutical company founded in 2017. Already the following year, Stenocare became the first Danish company to obtain permits to cultivate, import, and handle medical cannabis oils in the Danish pilot Programme.

DecideAct A/S

Gemstone acted as financial advisor in DecideAct’s convertible loan of 5 mDKK

DecideAct is a provider of SaaS software and solutions that move strategy execution and follow-up from manual execution to a cloud-based Strategy Execution Management platform.